Loading…

Biocompatibility and osseointegration of β-TCP: Histomorphological and biomechanical studies in a weight-bearing sheep model

The aim of the study was to investigate the biocompatibility, degradation, and biomechanical properties of β‐TCP (Cerasorb®) in a weight‐bearing sheep model. β‐TCP implant prototypes were implanted in the tibial head of adult merino sheep. After 6 and 12 months material explants were harvested for b...

Full description

Saved in:
Bibliographic Details
Published in:Journal of biomedical materials research 2004-08, Vol.70B (2), p.209-217
Main Authors: Koepp, Holger E., Schorlemmer, Sandra, Kessler, Stefan, Brenner, Rolf E., Claes, Lutz, Günther, Klaus-Peter, Ignatius, Anita A.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The aim of the study was to investigate the biocompatibility, degradation, and biomechanical properties of β‐TCP (Cerasorb®) in a weight‐bearing sheep model. β‐TCP implant prototypes were implanted in the tibial head of adult merino sheep. After 6 and 12 months material explants were harvested for biomechanical, histological, and histomorphometrical analysis. Corresponding bone specimens of the intact bone of the contralateral leg were used as controls in the biomechanical test. Compression tests showed higher values for maximum fracture load, yield strength, and compression modulus after 6 and 12 months compared to control. Microscopically, the implants showed good osteoconduction and were incorporated into the bone; however, relevant amounts of β‐TCP were still present after 12 months. Histomorphological results revealed that β‐TCP had partially degraded between implantation and 6 months, but its share remained constant between 6 and 12 months. The bone volume fraction in the area of the implant (46% ± 6.5%) was initially higher than in the corresponding bone area of the contralateral leg (31% ± 9.6%), but after 12 months declined to 29% ± 9.4% (control: 33% ± 8.3%), while the share of β‐TCP remained constant at 36% ± 12.2%. These findings were supported by microradiographic data. In conclusion, in a weight bearing implantation model β‐TCP showed good biocompatibility, osseointegration and beginning degradation, even though it was not further degraded between 6 and 12 months. © 2004 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 70B: 209–217, 2004
ISSN:1552-4973
0021-9304
1552-4981
DOI:10.1002/jbm.b.30034